𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus

✍ Scribed by S. Chitrabamrung; R. L. Rubin; E. M. Tan

Publisher
Springer
Year
1981
Tongue
English
Weight
518 KB
Volume
1
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Measurement of systemic lupus erythemato
Measurement of systemic lupus erythematosus activity in clinical research
✍ Matthew H. Liang; Steven A. Socher; W. Neal Roberts; John M. Esdaile πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 881 KB

The judgment of whether a patient with systemic lupus erythematosus (SLE) is better or worse is a central question in patient management. Yet, John L. Decker's lament is still cogent (1): The management of systemic lupus erythematosus today is rather more of an art than a science. An artistic endea

Network analysis of associations between
Network analysis of associations between serum interferon-Ξ± activity, autoantibodies, and clinical features in systemic lupus erythematosus
✍ Corinna E. Weckerle; Beverly S. Franek; Jennifer A. Kelly; Marissa Kumabe; Rache πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 188 KB πŸ‘ 1 views

## Abstract ## Objective Interferon‐α (IFNΞ±) is a primary pathogenic factor in systemic lupus erythematosus (SLE), and high IFNΞ± levels may be associated with particular clinical manifestations. The prevalence of individual clinical and serologic features differs significantly by ancestry. This st